PACB Pacific Biosciences of California, Inc. Stock Quote

PACB [NASD]

Pacific Biosciences of California, Inc.

Healthcare | Diagnostics & Research | USA

Index	-	P/E	408.81	EPS (ttm)	0.08	Insider Own	1.30%	Shs Outstand	193.10M	Perf Week	-7.49%
Market Cap	6.51B	Forward P/E	-	EPS next Y	-0.76	Insider Trans	-70.45%	Shs Float	184.26M	Perf Month	6.15%
Income	29.40M	PEG	-	EPS next Q	-0.40	Inst Own	94.62%	Short Float	5.27%	Perf Quarter	122.55%
Sales	78.90M	P/S	82.57	EPS this Y	27.30%	Inst Trans	9.55%	Short Ratio	1.75	Perf Half Y	435.73%
Book/sh	0.78	P/B	44.03	EPS next Y	21.60%	ROA	-22.80%	Target Price	51.50	Perf Year	898.26%
Cash/sh	1.10	P/C	31.25	EPS next 5Y	-1.00%	ROE	-71.30%	52W Range	2.20 - 53.69	Perf YTD	32.38%
Dividend	-	P/FCF	443.20	EPS past 5Y	10.10%	ROI	-116.60%	52W High	-38.96%	Beta	1.14
Dividend %	-	Quick Ratio	1.70	Sales past 5Y	8.40%	Gross Margin	41.30%	52W Low	1389.55%	ATR	4.19
Employees	404	Current Ratio	1.80	Sales Q/Q	-12.80%	Oper. Margin	-63.70%	RSI (14)	43.32	Volatility	11.40% 9.70%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	25.40%	Profit Margin	-64.70%	Rel Volume	0.87	Prev Close	34.34
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Feb 10 AMC	Payout	-	Avg Volume	5.54M	Price	32.77
Recom	2.40	SMA20	-16.49%	SMA50	-4.60%	SMA200	115.67%	Volume	1,985,152	Change	-4.57%

Feb-11-21

Upgrade

Piper Sandler

Neutral → Overweight

$20 → $52

Nov-03-20

Downgrade

Piper Sandler

Overweight → Neutral

$12

Oct-02-20

Upgrade

JP Morgan

Neutral → Overweight

$15

Sep-09-20

Initiated

Morgan Stanley

Equal-Weight

Jun-02-20

Resumed

Cantor Fitzgerald

Overweight

Mar-09-20

Resumed

Cantor Fitzgerald

Overweight

Oct-15-19

Upgrade

Piper Jaffray

Neutral → Overweight

Apr-02-19

Downgrade

Stephens

Overweight → Equal-Weight

$4.50 → $8

Oct-19-18

Initiated

Cowen

Outperform

Nov-03-17

Downgrade

First Analysis Sec

Overweight → Equal-Weight

Sep-28-17

Downgrade

CL King

Buy → Neutral

Nov-03-16

Reiterated

Cantor Fitzgerald

Buy

$18 → $15

Jun-27-16

Initiated

CL King

Buy

Apr-15-16

Initiated

First Analysis Sec

Overweight

$11

Feb-04-16

Downgrade

Piper Jaffray

Overweight → Neutral

Jan-04-16

Reiterated

Cantor Fitzgerald

Buy

$11 → $18

Oct-23-15

Upgrade

Piper Jaffray

Neutral → Overweight

Aug-27-15

Initiated

Cantor Fitzgerald

Buy

Feb-04-15

Reiterated

Maxim Group

Buy

$10 → $11

Sep-26-13

Reiterated

Maxim Group

Buy

$4 → $8

Mar-02-21 04:30PM	Pacific Biosciences Grants Equity Incentive Award to New Employee GlobeNewswire
Feb-26-21 04:04PM	Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences GlobeNewswire
Feb-24-21 08:00AM	Childrens Mercy Kansas City Expands Investment in Pacific Biosciences Sequel IIe Systems to Scale Up Whole Genome Research Initiatives Focused on Rare Disease Diagnosis GlobeNewswire
Feb-19-21 09:50AM	Teladoc Stock Helps Fuel Big Gains In Hot Genome Play Near Buy Point Investor's Business Daily
Feb-18-21 08:01AM	Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19 GlobeNewswire
Feb-12-21 12:08AM	Results: Pacific Biosciences of California, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts Simply Wall St.
Feb-11-21 12:24PM	Pacific Biosciences (PACB) Q4 Earnings and Revenues Miss Estimates Zacks +11.44%
08:24AM	Pacific Bio Shares Spike 9% Pre-Market As SoftBank Invests $900M SmarterAnalyst
06:00AM	How Pacific Biosciences Beat Expectations in Q4 Motley Fool
Feb-10-21 09:31PM	Pacific Biosciences of California (PACB) Q4 2020 Earnings Call Transcript Motley Fool +16.08%
07:41PM	Here's Why Pacific Biosciences of California Stock Popped Today Motley Fool
07:30PM	Here's Why Pacific Biosciences Stock Popped Today Motley Fool
05:15PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Misses Revenue Estimates Zacks
04:24PM	Pacific Biosciences: Q4 Earnings Insights Benzinga
04:02PM	Pacific Biosciences of California, Inc. Announces Fourth Quarter and Fiscal Year 2020 Financial Results GlobeNewswire
02:30PM	Pacific Biosciences of California, Inc. to Host Earnings Call ACCESSWIRE
12:26PM	Why Pacific Biosciences of California Stock Is Soaring Today Motley Fool
10:28AM	Pacific Biosciences stock rockets ahead of earnings, after Softbank makes $900 million investment MarketWatch
08:45AM	SoftBank to invest $900 million in gene sequencing firm Pacific Biosciences Reuters
08:44AM	UPDATE 1-SoftBank to invest $900 mln in gene sequencing firm Pacific Biosciences Reuters
08:41AM	Pacific Biosciences Rises as SoftBank Invests $900 Million TheStreet.com
08:00AM	Pacific Biosciences Announces $900 Million Investment from SoftBank to Support Growth Initiatives GlobeNewswire
05:20AM	SoftBank To Invest $900M In Pacific Biosciences - WSJ Benzinga
Feb-09-21 10:23AM	Pacific Biosciences Earnings Preview Benzinga
09:29AM	What's in Store for Pacific Biosciences' (PACB) Q4 Earnings? Zacks
Feb-05-21 05:00PM	Pacific Biosciences Grants Equity Incentive Award to New Employee GlobeNewswire
Feb-02-21 12:24PM	Is Pacific Biosciences of California (PACB) Stock a Buy For 2021? Insider Monkey
06:12AM	Is Pacific Biosciences of California a Ticking Time Bomb for Investors? Motley Fool
Jan-29-21 04:15PM	Pacific Biosciences Grants Equity Incentive Award to New Employee GlobeNewswire -5.63%
Jan-27-21 02:30PM	Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call GlobeNewswire -5.54%
Jan-26-21 11:05AM	Accuray (ARAY) Releases Encouraging Breast Cancer Study Results Zacks -8.54%
Jan-20-21 11:36AM	Why You Should Retain Pacific Biosciences (PACB) Stock Now Zacks
Jan-13-21 12:19PM	Pacific Biosciences Reaches Our Price Target: Now What? TheStreet.com
11:15AM	Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues Zacks
08:02AM	Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform GlobeNewswire
Jan-12-21 06:26PM	Pacific Biosciences Grants Equity Incentive Awards to New Employees GlobeNewswire
Jan-11-21 07:45AM	Pacific Biosciences of California, Inc. Announces Preliminary Fourth Quarter 2020 Revenue GlobeNewswire -6.65%
Jan-08-21 03:16PM	SoftBank Takes Stake in DNA Firm Pacific Biosciences Bloomberg +11.58%
08:45AM	Pacific Biosciences Announces Appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer GlobeNewswire
08:00AM	Wellcome Sanger Institute Increases Investment in PacBio Long-Read Sequencing to Support Darwin Tree of Life Research Initiative GlobeNewswire
Jan-07-21 09:13AM	3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021 Zacks +16.22%
Jan-01-21 01:31AM	Calculating The Fair Value Of Pacific Biosciences of California, Inc. (NASDAQ:PACB) Simply Wall St.
Dec-31-20 05:00AM	The Best Stock Picker of 2020 Wins With Disruptive DNA Bloomberg
Dec-24-20 11:10AM	Top ETF of December & Its Best Stocks Zacks
Dec-23-20 07:29PM	12 Best Genomic Stocks to Buy Now Insider Monkey +5.75%
08:37AM	Implied Volatility Surging for Pacific Biosciences (PACB) Stock Options Zacks
Dec-18-20 04:05PM	Pacific Biosciences Grants Equity Incentive Award to New Employee GlobeNewswire
Dec-16-20 08:00AM	SARS-CoV-2 Viral Genome Sequencing Data Presented from Research Using Pacific Biosciences Technology GlobeNewswire
Dec-14-20 08:00AM	Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads GlobeNewswire
Dec-10-20 10:02AM	Three High-Flying Biotech Stocks FX Empire
Dec-09-20 12:04PM	Watch Out, Pacific Biosciences Stock Is Very Extended TheStreet.com -6.79%
Dec-03-20 12:36PM	Should Value Investors Buy Pacific Biosciences of California (PACB) Stock? Insider Monkey +5.28%
12:15PM	Why You Should Retain Pacific Biosciences (PACB) Stock Now Zacks
Dec-02-20 11:30AM	Pacific Biosciences (PACB) Up 41.2% Since Last Earnings Report: Can It Continue? Zacks
Nov-11-20 12:21AM	Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock GlobeNewswire +12.35%
Nov-10-20 04:05PM	Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Nov-04-20 08:39AM	Pacific Biosciences (PACB) Loses 4.1% Post Reporting Q3 Loss Zacks
Nov-03-20 06:15AM	Why Pacific Biosciences of California Hit a Speed Bump With Its Q3 Results Motley Fool
05:19AM	Are Institutions Heavily Invested In Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Shares? Simply Wall St.
04:02AM	Pacific Biosciences of California (PACB) Q3 2020 Earnings Call Transcript Motley Fool
Nov-02-20 06:15PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates Zacks
04:46PM	Pacific Biosciences: Q3 Earnings Insights Benzinga
04:02PM	Pacific Biosciences of California, Inc. Announces Third Quarter 2020 Financial Results GlobeNewswire
02:30PM	Pacific Biosciences of California, Inc. to Host Earnings Call ACCESSWIRE
Oct-30-20 12:51PM	Medical Products Earnings Due on Nov 2: STE, HSIC & More Zacks
Oct-26-20 12:31PM	Pacific Biosciences of California (PACB) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Oct-22-20 08:00AM	Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics GlobeNewswire +5.23%
Oct-19-20 12:30PM	Pacific Biosciences of California, Inc. Third Quarter 2020 Financial Results Call GlobeNewswire
Oct-15-20 08:00AM	Childrens Mercy Kansas City Teams Up with Pacific Biosciences to Fight Rare Disease GlobeNewswire
Oct-08-20 11:30AM	Pacific Biosciences Unveils Sequel IIe for HiFi Sequencing Zacks
Oct-06-20 07:44PM	Hedge Funds Are Coming Back To Pacific Biosciences of California, Inc. (PACB) Insider Monkey
Oct-05-20 08:00AM	Pacific Biosciences Launches the Sequel IIe System to Accelerate Adoption of Highly Accurate HiFi Sequencing GlobeNewswire +8.80%
Oct-02-20 03:37PM	Why Pacific Biosciences of California Stock Jumped Today Motley Fool +11.52%
12:00PM	Are You Looking for a Top Momentum Pick? Why Pacific Biosciences of California (PACB) is a Great Choice Zacks
Sep-23-20 08:59AM	Pacific Biosciences (PACB) Looks Good: Stock Adds 5.3% in Session Zacks
Sep-22-20 07:13AM	Pacific Biosciences' Shares March Higher, Can It Continue? Zacks +5.34%
Sep-16-20 11:55AM	Illumina in talks to buy cancer testing startup Grail - Bloomberg News Reuters +7.51%
Sep-14-20 09:00AM	Pacific Biosciences Announces New Chief Financial Officer GlobeNewswire
Sep-09-20 09:44AM	Benzinga's Top Upgrades, Downgrades For September 9, 2020 Benzinga
Sep-02-20 11:30AM	Pacific Biosciences (PACB) Up 82.4% Since Last Earnings Report: Can It Continue? Zacks
Aug-18-20 08:43AM	Pacific Biosciences (PACB) Catches Eye: Stock Jumps 6.6% Zacks
Aug-12-20 12:51PM	Why Pacific Biosciences of California Shares Are Soaring Today Motley Fool +23.49%
Aug-11-20 11:20PM	Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock GlobeNewswire -5.10%
04:32PM	Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Aug-10-20 01:02PM	Did Hedge Funds Make The Right Call On Pacific Biosciences of California, Inc. (PACB) ? Insider Monkey
Aug-07-20 08:30AM	Pacific Biosciences Announces New Chief Executive Officer GlobeNewswire +15.93%
Aug-04-20 08:14AM	Pacific Biosciences (PACB) Posts Lower-Than-Expected Q2 Loss Zacks
06:40AM	What's Behind Pacific Biosciences of California's Ugly Q2 Results? Motley Fool
02:01AM	Pacific Biosciences of California (PACB) Q2 2020 Earnings Call Transcript Motley Fool
Aug-03-20 06:35PM	Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:02PM	Pacific Biosciences of California, Inc. Announces Second Quarter 2020 Financial Results GlobeNewswire
08:05AM	Pacific Biosciences and Asuragen Collaborate to Develop Assays for Carrier Screening and other Applications Based on SMRT Sequencing Technology and AmplideX PCR Chemistry Business Wire
08:00AM	Pacific Biosciences and Asuragen Collaborate to Develop Assays for Carrier Screening and other Applications Based on SMRT Sequencing Technology and AmplideX PCR Chemistry GlobeNewswire
Aug-02-20 11:08AM	The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings Benzinga
Jul-27-20 12:31PM	Analysts Estimate Pacific Biosciences of California (PACB) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-24-20 12:07PM	Pacific Biosciences of California, Inc. Second Quarter 2020 Financial Results Call GlobeNewswire -7.14%
Jun-23-20 01:21PM	Hedge Funds Are Selling Pacific Biosciences of California, Inc. (PACB) Insider Monkey
Jun-10-20 08:59AM	Pacific Biosciences Announces Planned Retirement of CEO, Dr. Michael Hunkapiller GlobeNewswire -8.21%
Jun-08-20 04:02PM	Pacific Biosciences of California, Inc. Announces Rescheduling of 2020 Annual Meeting of Stockholders and Move to Virtual Meeting GlobeNewswire
Jun-05-20 11:31AM	Pacific Biosciences (PACB) Up 8.1% Since Last Earnings Report: Can It Continue? Zacks +7.18%

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. The company also provides consumable products, including SMRT cells, as well as various reagent kits designed for specific workflow such as template preparation to convert DNA into SMRTbell double-stranded DNA library formats including molecular biology reagents, such as ligase, buffers and exonucleases. In addition, it provides binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprises reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences has collaboration with Asuragen to develop assays for carrier screening and other applications based on SMRT sequencing technology and AmplideX PCR chemistry; Invitae Corporation focuses on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. has collaboration with Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hunkapiller Michael	Director	Feb 26	Option Exercise	6.36	234,246	1,490,207	1,082,651	Mar 02 08:31 PM
Hunkapiller Michael	Director	Feb 26	Sale	31.02	234,246	7,265,866	848,405	Mar 02 08:31 PM
Hunkapiller Michael	Director	Feb 25	Option Exercise	6.40	339,377	2,172,291	1,187,782	Feb 26 08:34 PM
Hunkapiller Michael	Director	Feb 25	Sale	32.33	339,377	10,972,944	848,405	Feb 26 08:34 PM
Hunkapiller Michael	Director	Feb 24	Option Exercise	6.05	266,427	1,613,096	1,114,832	Feb 26 08:34 PM
Hunkapiller Michael	Director	Feb 24	Sale	36.80	266,427	9,805,281	848,405	Feb 26 08:34 PM
Hunkapiller Michael	Director	Feb 23	Option Exercise	5.97	373,321	2,227,849	1,221,726	Feb 24 08:50 PM
Hunkapiller Michael	Director	Feb 23	Sale	34.88	373,321	13,022,317	848,405	Feb 24 08:50 PM
Hunkapiller Michael	Director	Feb 22	Option Exercise	5.53	229,127	1,266,251	1,077,532	Feb 24 08:50 PM
Schaefer Eric	Chief Accounting Officer	Feb 22	Sale	39.20	3,842	150,606	88,474	Feb 24 08:21 PM
Hunkapiller Michael	Director	Feb 22	Sale	39.14	229,127	8,967,407	848,405	Feb 24 08:50 PM
ORDONEZ KATHY	Director	Feb 16	Option Exercise	4.92	185,879	915,243	242,646	Feb 18 09:52 PM
ORDONEZ KATHY	Director	Feb 16	Sale	47.99	220,771	10,595,810	21,875	Feb 18 09:52 PM
Botstein David	Director	Feb 12	Option Exercise	4.42	160,000	706,800	160,000	Feb 17 09:15 PM
LIVINGSTON RANDALL S	Director	Feb 12	Option Exercise	4.36	67,500	294,400	67,500	Feb 17 09:17 PM
Shapiro Lucy	Director	Feb 12	Sale	50.40	101,666	5,123,966	0	Feb 17 09:19 PM
LIVINGSTON RANDALL S	Director	Feb 12	Sale	48.07	67,500	3,244,455	0	Feb 17 09:17 PM
Botstein David	Director	Feb 12	Sale	49.62	160,000	7,939,764	0	Feb 17 09:15 PM
Hunkapiller Michael	Director	Jan 25	Option Exercise	6.14	125,406	769,993	973,811	Jan 27 05:07 PM
Hunkapiller Michael	Director	Jan 25	Sale	36.34	125,406	4,556,901	848,405	Jan 27 05:07 PM
Hunkapiller Michael	Director	Jan 22	Option Exercise	6.14	150,857	926,262	999,262	Jan 22 09:49 PM
Hunkapiller Michael	Director	Jan 22	Sale	36.77	150,857	5,547,490	848,405	Jan 22 09:49 PM
Hunkapiller Michael	Director	Jan 21	Option Exercise	3.31	208,711	691,411	1,106,926	Jan 22 09:49 PM
Hunkapiller Michael	Director	Jan 21	Sale	36.58	258,521	9,457,071	848,405	Jan 22 09:49 PM
Hunkapiller Michael	Director	Jan 20	Option Exercise	2.27	215,026	488,109	1,113,241	Jan 22 09:49 PM
Hunkapiller Michael	Director	Jan 20	Sale	39.19	215,026	8,426,269	898,215	Jan 22 09:49 PM
Hunkapiller Michael	Director	Dec 22	Option Exercise	3.01	364,451	1,096,998	1,262,666	Dec 23 06:34 PM
Hunkapiller Michael	Director	Dec 22	Sale	25.62	364,451	9,335,716	898,215	Dec 23 06:34 PM
Hunkapiller Michael	Director	Dec 21	Option Exercise	2.88	335,549	965,877	1,233,764	Dec 23 06:34 PM
Hunkapiller Michael	Director	Dec 21	Sale	23.00	335,549	7,718,327	898,215	Dec 23 06:34 PM
Hunkapiller Michael	Director	Nov 24	Sale	14.39	1,492	21,462	0	Nov 25 04:46 PM
Hunkapiller Michael	Director	Nov 23	Sale	15.03	251,837	3,785,614	1,492	Nov 24 04:44 PM
Hunkapiller Michael	Director	Nov 20	Sale	15.11	147,799	2,233,538	253,329	Nov 24 04:44 PM
Hunkapiller Michael	Director	Nov 19	Sale	15.55	2,201	34,226	401,128	Nov 20 05:16 PM
Hunkapiller Michael	Director	Nov 18	Sale	15.71	38,381	603,004	403,329	Nov 20 05:16 PM
Hunkapiller Michael	Director	Nov 16	Sale	15.90	42,488	675,347	441,710	Nov 18 04:05 PM
Hunkapiller Michael	Director	Nov 12	Sale	16.73	200,000	3,345,800	484,198	Nov 13 05:17 PM
Hunkapiller Michael	Director	Nov 11	Sale	16.46	250,000	4,116,000	684,198	Nov 13 05:17 PM
Hunkapiller Michael	Director	Nov 11	Sale	14.25	195,652	2,788,041	898,215	Nov 13 05:17 PM
Hunkapiller Michael	Director	Nov 10	Sale	14.25	1,304,348	18,586,959	1,093,867	Nov 13 05:17 PM
Hunkapiller Michael	CEO & President	Aug 25	Sale	6.44	228,632	1,472,619	934,198	Aug 26 05:08 PM
MILLIGAN JOHN F	Director	Aug 24	Option Exercise	3.32	110,000	365,200	110,000	Aug 26 07:29 PM
Hunkapiller Michael	CEO & President	Aug 24	Sale	6.63	259,164	1,719,475	1,162,830	Aug 26 05:08 PM
Hunkapiller Michael	CEO & President	Aug 21	Sale	6.57	189,847	1,246,915	1,421,994	Aug 24 06:04 PM
Hunkapiller Michael	CEO & President	Aug 20	Sale	6.47	256,554	1,659,802	1,611,841	Aug 24 06:04 PM
Phillips James Michael	SVP, Research & Development	Mar 24	Sale	3.05	2,760	8,421	249,220	Mar 24 06:12 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience